Study: Antibody drug benefits patients with severe asthma

03/5/2009 | BBC

U.K. and Canadian researchers found that mepolizumab, an antibody treatment, effectively reduced asthma attacks and dependence on steroids in patients with severe asthma worsened by eosinophilia, a type of persistent airway inflammation. The antibody drug works by inhibiting the production of eosinophils, white blood cells that can cause eosinophilia when in high levels, one of the researchers said.

View Full Article in:


Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Chief Executive Officer
Center for Improving Value in Healthcare
Denver, CO
Quality Program Manager II, State Programs
Tufts Health Plan
Watertown, MA
Associate Director, Promotion Integrity
Bristol-Myers Squibb
Plainsboro, NJ
Vice President, Medicare Advantage
Baton Rouge, LA
Director, Global Integrity and Compliance, Pharmaceuticals
Fort Worth, TX